Cell And Gene Therapy Videos

1. Comprehensive, Integrated BioServices 5/2/2025

   Discover more about optimized storage, packing, labeling, and global distribution, seamlessly integrated for your supply chain. Simplify complexity and enhance the reliability of your supply chain.

2. Harnessing Potential: Innovations And Improvements In Viral Gene Therapy 4/28/2025

   Review the potential of AAV-mediated gene therapy as a platform approach to treat multiple genetic neurological diseases, and explore suggestions to streamline translational studies and reduce costs.

3. FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

   In this presentation, Serat Ali, Director of Commercial Development, describes FUJIFILM Diosynth Biotechnologies' Advanced Therapy capabilities, discusses their global facilities network, and provides a capacity update.

4. Vinta Bio Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

   Uncover how an intensified adherent AAV manufacturing process is unlocking high-yield, low-impurity clinical production with over 95% full capsids in a streamlined, compact platform.

5. Kincell Bio Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

   Explore how expert CMC strategies and clinical manufacturing experience can lay the groundwork for the successful commercialization of advanced cell therapies.

6. Comprehensive Cell Solutions Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

   Discover how NYBCe and CCS are transforming cell and gene therapy development with end-to-end CDMO solutions, advanced logistics, and a growing innovation hub in Louisville.

7. Miltenyi Biotec B.V. & Co. KG Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

   In this presentation, Shaan Gareeb highlights the capabilities of our Cell Therapy Center of Excellence in San Jose, California, one of five global Miltenyi Bioindustry sites.

8. Andelyn Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

   Here, we discuss how proper optimization leads to success in both scale-up and scale-down models for AAV production by focusing on critical parameters such as cell culture conditions, viral vector yield, and downstream purification strategies.

9. SK pharmteco Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

   Discover how our integrated expertise — from plasmid science to viral vector and cell therapy manufacturing — can accelerate and de-risk the development of your advanced therapies.

10. Advancing Cell & Gene Therapies To Patients 4/24/2025

    Discover how we apply our expertise and know-how to efficiently advance your viral vector-based therapeutic through any phase, while enhancing quality and de-risking production.